Cargando…

Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder

Background: Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune-related neurological disorder of the central nervous system. Most patients with NMOSD have serum anti-aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). In addition to optic neuritis and myelitis, other insidious s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akaishi, Tetsuya, Takahashi, Toshiyuki, Fujihara, Kazuo, Misu, Tatsuro, Fujimori, Juichi, Takai, Yoshiki, Nishiyama, Shuhei, Abe, Michiaki, Ishii, Tadashi, Aoki, Masashi, Nakashima, Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938311/ https://www.ncbi.nlm.nih.gov/pubmed/33692739 http://dx.doi.org/10.3389/fneur.2021.608149

Ejemplares similares

Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Optic neuritis after ocular trauma in anti‐aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2023)

CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
por: Namatame, Chihiro, et al.
Publicado: (2021)

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
por: Takai, Yoshiki, et al.
Publicado: (2023)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody
por: Kurosawa, Kazuhiro, et al.
Publicado: (2015)

Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica
por: Misu, Tatsuro, et al.
Publicado: (2013)

Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence
por: Akaishi, Tetsuya, et al.
Publicado: (2019)

Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder
por: Asato, Yuko, et al.
Publicado: (2018)

Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica
por: Nishiyama, S., et al.
Publicado: (2016)

Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
por: Hillebrand, Sophie, et al.
Publicado: (2018)

MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
por: Ogawa, Ryo, et al.
Publicado: (2017)

Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery
por: Fujimori, Juichi, et al.
Publicado: (2017)

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Epitope Analysis of Cerebrospinal Fluid IgG in Japanese Multiple Sclerosis Patients Using Phage Display Method
por: Fujimori, Juichi, et al.
Publicado: (2011)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Neuromyelitis optica spectrum disorders: still evolving and broadening
por: Fujihara, Kazuo
Publicado: (2019)

T cell-activation in neuromyelitis optica lesions plays a role in their formation
por: Pohl, Maria, et al.
Publicado: (2013)

Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica
por: Kariya, Yoshinobu, et al.
Publicado: (2015)

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin
por: Matsumoto, Yuki, et al.
Publicado: (2018)

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
por: Kitic, Maja, et al.
Publicado: (2013)

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
por: Kaneko, Kimihiko, et al.
Publicado: (2018)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S., et al.
Publicado: (2008)

Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
por: Mader, Simone, et al.
Publicado: (2010)

Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
por: Wingerchuk, Dean M., et al.
Publicado: (2021)

Differential diagnosis of neuromyelitis optica spectrum disorders
por: Kim, Sung-Min, et al.
Publicado: (2017)

Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan
por: Nakashima, Ichiro, et al.
Publicado: (2023)

Paraneoplastic Neuromyelitis Optica Spectrum Disorder Related to Glucose-regulated Protein 78 (GRP78) Autoantibodies in a Patient with Lynch Syndrome-associated Colorectal Cancer
por: Minomo, Shogo, et al.
Publicado: (2022)

Serological markers associated with neuromyelitis optica spectrum disorders in South India
por: Pandit, Lekha, et al.
Publicado: (2016)

Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2013)

Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica
por: Nelson, Patricia A., et al.
Publicado: (2010)

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders
por: Tzartos, John S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8tb14qpfanu8gj4j4f84u6g4e7